CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY
View/Open
Access
info:eu-repo/semantics/openAccessDate
13.09.2022Author
Gürsu, MeltemÖztürk, Savaş
Arıcı, Mustafa
Şahin, İdris
Gökçay Bek, Sibel
Yılmaz, Mürvet
Koyuncu, Sümeyra
Karahisar Şirali, Semahat
Ural, Zeynep
Dursun, Belda
Yüksel, Enver
Uzun, Sami
Sipahi, Savaş
Ahbap, Elbis
Artan, Ayşe Serra
Altunören, Orçun
Tunca, Onur
Ayar, Yavuz
Gök Oğuz, Ebru
Yılmaz, Zülfükar
Kahvecioğlu, Serdar
Aşıcıoğlu, Ebru
Oruç, Ayşegül
Altıparmak, Mehmet Rıza
Aydın, Zeki
Huddam, Bülent
Dölarslan, Mürşide Esra
Azak, Alper
Bakırdöğen, Serkan
Yalçın, Ahmet Uğur
Karadağ, Serhat
Ulu, Memnune Sena
Güngör, Özkan
Arı Bakır, Elif
Odabaş, Ali Rıza
Seyahi, Nurhan
Yıldız, Alaattin
Ateş, Kenan
Metadata
Show full item recordCitation
Gursu, M., Ozturk, S., Arici, M., Sahin, I., Bek, S. G., Yilmaz, M., ... & Ates, K. (2022). CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEAL DIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY: A MULTICENTER NATIONAL STUDY. Kidney and Blood Pressure Research.Abstract
Introduction: We aimed to study the characteristics of peritoneal dialysis (PD) patients with Coronavirus disease-19
(COVID-19), determine the short-term mortality and other medical complications, and delineate the factors
associated with COVID-19 outcome.
Methods: In this multicenter national study, we included PD patients with confirmed COVID-19 from 27 centers. The
baseline demographic, clinical, laboratory, and radiological data and outcomes at the end of the first month were
recorded.
Results: We enrolled 142 COVID-19 patients (median age:52 years). 58.2% of patients had mild disease at diagnosis.
Lung involvement was detected in 60.8% of patients. 83 (58.4%) patients were hospitalized, 31 (21.8%) patients were
admitted to intensive care unit and 24 needed mechanical ventilation. 15 (10.5%) patients were switched to
hemodialysis and hemodiafiltration was performed for four (2.8%) patients. Persisting pulmonary symptoms (n=27),
lower respiratory system infection (n=12), rehospitalization for any reason (n=24), malnutrition (n=6), hypervolemia
(n=13), peritonitis (n=7), ultrafiltration failure (n=7) and in PD modality change (n=8) were reported in survivors. 26
patients (18.31%) died in the first month of diagnosis. The non-survivor group was older, comorbidities were more
prevalent. Fever, dyspnea, cough, serious-vital disease at presentation, bilateral pulmonary involvement, and pleural
effusion were more frequent among non-survivors. Age (OR:1.102; 95%CI: 1.032-1.117; p: 0.004), moderate-severe
clinical disease at presentation (OR:26.825; 95%CI: 4.578-157.172; p<0.001) and baseline CRP (OR:1.008; 95%CI;
1.000-1.016; p:0.040) were associated with first-month mortality in multivariate analysis.
Discussion/Conclusions: Early mortality rate and medical complications are quite high in PD patients with COVID-19.
Age, clinical severity of COVID-19, and baseline CRP level are the independent parameters associated with mortality.